Pastorino U, Valente M, Bedini V, Infante M, Tavecchio L, Ravasi G
Department of Thoracic Surgery, Istituto Nazionale Tumori, Milan, Italy.
Eur J Surg Oncol. 1991 Feb;17(1):42-6.
We have reviewed our experience of limited resections for Stage I lung cancer for the years 1971-88. Sixty-one cases of sublobar resection (wedge or segmental) were compared with 411 lobar resections (lobectomies or bilobectomies), performed over the same period. Operative mortality was 0% in the limited resection group and 3% (12/411) in the control group. Cancer recurrence was detected respectively in 36% and 38% of patients, and actuarial survival at 5 years was 55% versus 49% overall. Sublobar resection had a slightly better outcome than lobar resection in pathological T1 (5-year survival of 73% vs 55%) but a worse outcome in pT2 (35% vs 46%); however, none of the differences was statistically significant. In 28 patients with pre-existing cardiac or pulmonary co-morbidity, limited resection yielded the same 5-year survival as lobectomy (53% vs 51%) with no peri-operative deaths (0 vs 5%). Although derived from a retrospective analysis, these data offer a further confirmation that limited resection combined with adequate nodal staging is a reliable and effective technique for early stage lung cancer management.
我们回顾了1971年至1988年间对I期肺癌进行有限切除的经验。将61例肺叶下切除(楔形或肺段切除)病例与同期进行的411例肺叶切除(肺叶切除术或双肺叶切除术)病例进行了比较。有限切除组的手术死亡率为0%,而对照组为3%(12/411)。分别在36%和38%的患者中检测到癌症复发,总体5年精算生存率分别为55%和49%。在病理T1期,肺叶下切除的结果略优于肺叶切除(5年生存率分别为73%和55%),但在pT2期则较差(35%和46%);然而,这些差异均无统计学意义。在28例术前存在心脏或肺部合并症的患者中,有限切除的5年生存率与肺叶切除术相同(53%和51%),且无围手术期死亡(0和5%)。尽管这些数据来自回顾性分析,但它们进一步证实,有限切除联合充分的淋巴结分期是早期肺癌治疗的一种可靠且有效的技术。